Jesús Ruiz-Aragón

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

General Practice

Stem Cell Transplantation

Top Venues

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Maarten Postma, David Fisman, Norberto D Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña, Joaquin F Mould-Quevedo
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion. Vaccines 11 (6) (2023)
Maarten Postma, David Fisman, Norberto D Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña, Joaquin F Mould-Quevedo
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion. Vaccines 11 (6) (2023)
Jesús Ruiz-Aragón, Sergio Márquez-Peláez, Ray Gani, Piedad Alvarez, Richard Guerrero-Luduena
Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain. Vaccines 10 (2) (2022)
Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez, Piedad Alvarez
Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain. Human vaccines & immunotherapeutics 16 (9) (2020)
Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez, Piedad Alvarez
Reply to letter from Alvarez et al. Human vaccines & immunotherapeutics 17 (3) (2020)